SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
NOVEL VACCINE CONCEPTS
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
A NOVEL VSV-BASED EBOLA/HIV-1 VACCINE PROVIDES PROTECTION IN MACAQUES FROM SHIV (ABSTRACT
267)
Eric J Arts
Western University, London, Ontario, Canada
DESIGN AND IMMUNOGENICITY OF V3-GLYCAN EPITOPE-FOCUSED NANOPARTICLES FOR HIV VACCINES (ABSTRACT
268)
Christine Nicole Daniels
Duke University, Durham, NC, USA
NANOPARTICLE-DCS RESTORE CYTOTOXIC MEMORY-LIKE NK CELLS IN CHRONIC HIV PATIENTS (ABSTRACT
269)
Ildefonso Sanchez Cerrillo
Hospital La Princesa, Madrid, Madrid, Spain
AAV-EXPRESSED ANTI-HIV BIOLOGICS BLOCK ORAL SHIV ACQUISITION IN INFANT RHESUS MONKEYS (ABSTRACT
270)
Mauricio A Martins
Scripps Research Florida, Jupiter, FL, USA
PROTECTION FROM SHIV INFECTION IN IMMUNE-COMPLEX VACCINATED RHESUS MACAQUES (ABSTRACT
271)
Qingbo Liu
NIAID, BETHESDA, USA
DUAL-ANTIGEN COVID-19 VACCINATION WITH ORAL BOOST PROTECTS NHP FROM VIRAL CHALLENGE (ABSTRACT
272)
Jeffrey T Safrit
NantKwest, Inc., Culver City, CA, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
